Fundraising Fox

Shift Labs

AcquiredYC W15

Seattle, US · Founded 2012 · Delaware corporation · 6 employees · 3 known investors

Shift Labs develops DripAssist, an FDA-cleared infusion rate monitor that enables safe delivery of gravity IV medications in home and out-of-hospital settings. The platform remotely tracks medication infusion rates and provides data analytics for healthcare providers administering home infusion therapy.

Digital HealthHardwareHealthtechMedical DevicesUnited States of AmericaAmerica / CanadaPartly Remote

Founders & leadership· Y Combinator alumni (W15)

Shift Labs was founded in 2012 by Beth Kolko.

BKBeth Kolko
Beth KolkoinFounder/CEOBeth Kolko founded Shift Labs and has invested through Pioneer Fund and Pack Ventures. She is also a professor at the University of Washington.
JM
Joseph MechlinskiExecutive

Investors · 3

Reported raises · per SEC filings

Form D private placements

$1.2M disclosed across 1 of 3 rounds · 2015–2023

Undisclosed amountofferedMar 2023 · Business Services
Rule 506(b)
Officers, directors & promoters on the filing
  • Joseph MechlinskiExecutive Officer
Minimum investment
$100K
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$1.5MofferedApr 2022 · Business Services
Rule 506(b)
Officers, directors & promoters on the filing
  • Joseph MechlinskiExecutive Officer, Director
Offering amount
$1.5M
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$1.2MraisedJul 2015 · 26 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Beth KolkoExecutive Officer, Director
Offering amount
$1.2M
Amount sold
$1.2M
Minimum investment
$1K
First sale
Mar 2015
Incorporated
Corporation, Washington, 2012
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 2

by search overlap

Companies competing with Shift Labs for the same Google search keywords, organic and paid, via search-intersection analysis.

Non-dilutive funding · 3 SBIR/STTR awards

Federal grants — no equity taken
AgencyPhaseYearAmount
National Institutes of Health (NIH)National Institutes of HealthPhase I2022$251.2K
U.S. Air ForceAir ForcePhase II2019$1.5M
U.S. Air ForceAir ForcePhase I2019$49.9K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

Frequently asked questions

What does Shift Labs do?
Shift Labs develops DripAssist, an FDA-cleared infusion rate monitor that enables safe delivery of gravity IV medications in home and out-of-hospital settings. The platform remotely tracks medication infusion rates and provides data analytics for healthcare providers administering home infusion therapy.
Who founded Shift Labs?
Shift Labs was founded by Beth Kolko in 2012.
Who are Shift Labs's investors?
Shift Labs's investors include Knockout Capital, SGH Capital, Y Combinator.
How much funding has Shift Labs raised?
Shift Labs has disclosed $1.2M raised across 1 of its 3 known rounds.
Where is Shift Labs headquartered?
Shift Labs is headquartered in Seattle, US.